A Comparison of Azopt Versus Placebo Added to Xalatan in Patients With Elevated Intraocular Pressure (IOP) on a Prostaglandin

PHASE4CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Glaucoma
Interventions
DRUG

Brinzolamide 1% ophthalmic solution (Azopt)

One drop three times a day in both eyes for 3 months

DRUG

Placebo eye drops

One drop three times a day in both eyes for 3 months

DRUG

Latanoprost 0.005% ophthalmic solution (Xalatan)

One drop once a day in both eyes for 3 months

Trial Locations (1)

76134

Contact Alcon Call Center for Trial Locations, Fort Worth

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT00759941 - A Comparison of Azopt Versus Placebo Added to Xalatan in Patients With Elevated Intraocular Pressure (IOP) on a Prostaglandin | Biotech Hunter | Biotech Hunter